Literature DB >> 11559822

Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer.

M Hillgenberg1, H Tönnies, M Strauss.   

Abstract

Helper-dependent minimal adenovirus vectors are promising tools for gene transfer and therapy because of their high capacity and the absence of immunostimulatory or cytotoxic viral genes. In order to characterize this new vector system with respect to its integrative properties, the integration pattern of a minimal adenovirus vector with a neo(r) gene inserted centrally into a noncoding 27.4-kb genomic stuffer element derived from the human X chromosome after infection of a sex chromosome aneuploid (X0) human glioblastoma cell line was studied. Our results indicate that even extensive homologies and abundant chromosomal repeat elements present in the vector did not lead to integration of the vector via homologous or homology-mediated mechanisms. Instead, integration occurred primarily by insertion of a monomer with no or little loss of sequences at the vector ends, apparently at random sites, which is very similar to E1 deletion adenovirus vectors. It is therefore unlikely that the incorporation of stuffer elements derived from human genomic DNA, which were shown to allow long-term transgene expression in vivo in a number of studies, leads to an enhanced risk of insertional mutagenesis. Furthermore, our findings indicate that the potential of minimal adenovirus vectors as tools for targeted insertion and gene targeting is limited despite the possibility of incorporating long stretches of homologous sequences. However, we found an enhanced efficiency of stable neo(r) transduction of the minimal adenovirus vector compared to an E1 deletion adenovirus vector, possibly caused by the absence of potential growth-inhibitory viral genes. Complete integration of the vector and tolerance of the integrated vector sequences by the cell might indicate a potential use of these vectors as tools for stable transfer of (large) genes.

Entities:  

Mesh:

Year:  2001        PMID: 11559822      PMCID: PMC114561          DOI: 10.1128/JVI.75.20.9896-9908.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

Review 1.  SINEs and LINEs share common 3' sequences: a review.

Authors:  N Okada; M Hamada; I Ogiwara; K Ohshima
Journal:  Gene       Date:  1997-12-31       Impact factor: 3.688

2.  Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

Authors:  G Schiedner; N Morral; R J Parks; Y Wu; S C Koopmans; C Langston; F L Graham; A L Beaudet; S Kochanek
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

Review 3.  Alu sequences.

Authors:  A J Mighell; A F Markham; P A Robinson
Journal:  FEBS Lett       Date:  1997-11-03       Impact factor: 4.124

4.  Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations.

Authors:  R Alemany; Y Dai; Y C Lou; E Sethi; E Prokopenko; S F Josephs; W W Zhang
Journal:  J Virol Methods       Date:  1997-11       Impact factor: 2.014

5.  Sensitivity and reproducibility in adenoviral infectious titer determination.

Authors:  C Nyberg-Hoffman; P Shabram; W Li; D Giroux; E Aguilar-Cordova
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

Review 6.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

7.  High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation.

Authors:  M Zeng; G J Cerniglia; S L Eck; C W Stevens
Journal:  Hum Gene Ther       Date:  1997-06-10       Impact factor: 5.695

8.  Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.

Authors:  Y Yang; Q Li; H C Ertl; J M Wilson
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.

Authors:  W Y Chen; E C Bailey; S L McCune; J Y Dong; T M Townes
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

10.  MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

Authors:  Y Yang; H C Ertl; J M Wilson
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

View more
  12 in total

Review 1.  Liver-directed gene therapy for dyslipidemia and diabetes.

Authors:  Kazuhiro Oka; Lawrence Chan
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

Review 2.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

Review 3.  Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.

Authors:  Ronald J Mandel; Corinna Burger; Richard O Snyder
Journal:  Exp Neurol       Date:  2007-08-24       Impact factor: 5.330

Review 4.  Helper-dependent adenoviral vectors in experimental gene therapy.

Authors:  Alicja Józkowicz; Józef Dulak
Journal:  Acta Biochim Pol       Date:  2005-08-04       Impact factor: 2.149

5.  Chromosomal integration of adenoviral vector DNA in vivo.

Authors:  Sam Laurel Stephen; Eugenio Montini; Vijayshankar Ganesh Sivanandam; Muhseen Al-Dhalimy; Hans A Kestler; Milton Finegold; Markus Grompe; Stefan Kochanek
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

6.  Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.

Authors:  K Oka; L M Belalcazar; C Dieker; E A Nour; P Nuno-Gonzalez; A Paul; S Cormier; J-K Shin; M Finegold; L Chan
Journal:  Gene Ther       Date:  2006-09-07       Impact factor: 5.250

7.  A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression.

Authors:  Hongjie Wang; Dmitry M Shayakhmetov; Tobias Leege; Michael Harkey; Qiliang Li; Thalia Papayannopoulou; George Stamatoyannopolous; André Lieber
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  A Novel Adenoviral Hybrid-vector System Carrying a Plasmid Replicon for Safe and Efficient Cell and Gene Therapeutic Applications.

Authors:  Richard Voigtlander; Rudolf Haase; Martin Mück-Hausl; Wenli Zhang; Philip Boehme; Hans-Joachim Lipps; Eric Schulz; Armin Baiker; Anja Ehrhardt
Journal:  Mol Ther Nucleic Acids       Date:  2013-04-02       Impact factor: 10.183

9.  Down-regulation of IL-8 expression in human airway epithelial cells through helper-dependent adenoviral-mediated RNA interference.

Authors:  Hui Bi Cao; Anan Wang; Bernard Martin; David R Koehler; Pamela L Zeitlin; A Keith Tanawell; Jim Hu
Journal:  Cell Res       Date:  2005-02       Impact factor: 25.617

Review 10.  The role of chromatin in adenoviral vector function.

Authors:  Carmen M Wong; Emily R McFall; Joseph K Burns; Robin J Parks
Journal:  Viruses       Date:  2013-06-14       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.